New Cohort and major partner for Tech4Eva Accelerator
Building on the success of its first two years, Tech4Eva, a unique international accelerator in Switzerland, has announced its new cohort at the 3rd edition kick-off organized in Kaiseraugst near Basel, in partnership with Roche. This year, Tech4Eva has attracted 147 projects from 40 countries, an increase of 18.5% with respect to the 2nd edition and 33.6% compared to the first. Interestingly 80% of the startups were once again created by women. Four Swiss startups are part of the new cohort.
For this third edition, the selection committee chose 21 startups from 147 applications from Switzerland and elsewhere in the world. 14 Swiss startups applied this year and four were selected by the jury.
The three most represented topics among startups offering innovative solutions in women's health are
- Menstruation and sexual health: 22% of start-ups
- Women's mental health and well-being: 18% of start-ups
- Pregnancy and postpartum: 15% of start-ups.
The solutions envisaged to respond to these challenges are numerous but focus on three major areas:
- Mobile application: 18%.
- Computer software: 16%.
- Medical devices: 14%.
These figures clearly show that in women's health too, digitalisation is at the heart of the reflections. Moreover, two Swiss projects selected perfectly reflect this reality:
- Adira Health is active in pregnancy and wellbeing. The startup empowers pregnant women suffering from high blood pressure, measuring their vitals, assessing their physical and mental wellbeing to provide real-time, data-informed guidance, through their blended maternity care pathway. Adira combines the power of AI with a personal perinatal coach to fight for healthy moms and stronger babies.
- HEALTHY-LONGER analyzes mental health symptoms together with the bio-chemical pathways of 21 essential neuro-biomarkers in dried urine probes for neuro-nutrient deficiencies. Based on this they provide their clients with personalized, effective and scientifically proven neuro-nutritional recommendations from foods available in most grocery shops.
The two other Swiss startups joining the new cohort are:
- WakeUp Pelvic is building a digital solution for pelvic physiotherapists and their patients.
- Beyond Genomix is a clinical stage Swiss medtech developing next generation technologies for non-coding DNA analysis. With a focus on reproductive health, the startup has developed the only infertility test in the world, capable of explaining every infertility including that of idiopathic patients, male and female, from the comfort of their home.
Selected International start-ups:
Care Mother www.caremother.in; Egal Pads https://padsonaroll.com; Hale https://en.halecommunity.com/; Hyivy Health www.hyivy.com; Intignus Biotech https://intignusbiotech.com; Luma Womb www.lumawomb.com; Malaica https://www.malaica.com; Manina Medtech https://maninamedtech.com/; MIMSolutions https://www.mim-solutions.ai/; Natal Cares https://www.natalcares.com; Neurora https://www.neuraura.com/looop; NuroKor Femtech https://www.mihna.co.uk/; Predilife https://www.predilife.com/; RuMedical www.rumedical.co.uk; Samphire Neuroscience samphireneuro.com; Selfcerve; The PalpaCo. www.palpa.cl
More info here: https://www.tech4eva.ch/startups
A promising new partnership with Roche
Roche is collaborating for the first time with the Tech4Eva accelerator by hosting the launch event at its premises in Kaiseraugst near Basel. With this partnership, Tech4Eva expands further in the German- speaking part of Switzerland and can count on a major healthcare player in Switzerland. Roche has a long history in the field and has been strongly committed to women’s health and driving innovation to advance healthcare. In 2022, Roche launched its long-term initiative, XProject, which aims to identify and remove the most critical barriers so women can fully and equitably access healthcare. This connection between Roche's XProject and Tech4Eva, initiated by the EPFL Innovation Park and Groupe Mutuel, will create great synergies to support start-ups active in advancing women's health.
The two actors intend to encourage the development of start-ups whose objective is to improve response to the needs and specificities of women's health. With the support of third party funding, a new Tech4Eva “Global South” cohort is being added this year to the main cohort to improve women’s general health condition in emerging countries.
We call for the contribution of NGOs, philanthropic foundations and impact funds to join the Tech4Eva cause in order to encourage local entrepreneurship and adapt new technologies developed in western countries to the needs of Global South regions
EPFL Innovation Park - Groupe Mutuel, a win-win partnership
The selected start-ups will benefit from one of the best health ecosystems in Europe. They will have access to international collaborations and investors thanks to the extensive network of the EPFL Innovation Park. They will also have access to a dynamic market, with one of the leading health insurance companies in Switzerland. The EPFL Innovation Park and Groupe Mutuel are pleased to continue this collaboration to improve women's health.